Untitled

Initiatives Webinar series with support from Medtronic* & Phillips* presents…“Derivation & Validation of a Novel Opioid-Induced Respiratory Depression Risk Prediction Tool”

Opioid-induced respiratory depression (OIRD), a form of respiratory compromise, is one of the leading avoidable patient safety issues. Respiratory compromise increases morbidity and mortality as well hospital inpatient costs. This presentation will discuss the results of a recent, multi-center study (PRODIGY, a Medtronic-sponsored study), which was designed to identify people at high risk for OIRD. Results showed that more than 40% of patients on the general care floor experienced OIRD. The investigators will share an easy-to use risk prediction tool they developed to identify patients at high risk that can lead to earlier interventions.

Presenters: Ashish K. Khanna, M.D., FCCP, FCCM  |  Carla Jungquist, NP, DNP

Continuing Education Credit for: Physicians, Nurses, Respiratory Therapists

• This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Credit.
• Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care.
• This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032

Support for this educational activity from Medtronic and Philips

Questions should be addressed to: webinar@saxecommunications.com

* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.